13 nov. L’hépatite virale constitue un problème de santé publique international, comparable à celui posé par d’autres grandes maladies transmissibles. VIH, hépatites virales et comorbidités: épidémiologie clinique et santé era: Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) CO3 . 29 nov. L’hépatite A est surveillée en France par la déclaration obligatoire . /Hepatites- virales/Hepatite-A/Comment-signaler-et-notifier-cette-maladie.
|Published (Last):||15 October 2010|
|PDF File Size:||11.70 Mb|
|ePub File Size:||17.12 Mb|
|Price:||Free* [*Free Regsitration Required]|
Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: Can the “seek, test, treat, and retain” strategy be effective in France? Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: An undetectable polymerase chain reaction signal in routine HIV plasma viral load monitoring is associated with better virological outcomes in patients receiving highly active antiretroviral therapy.
Case Rep Oncol Med. Pharmacokinetic interaction between maraviroc and etravirine in HIV-infected patients receiving regimens containing both drugs and no ritonavir-boosted protease inhibitor.
Results of a large French prospective cohort. Facebook Twitter Google Plus fr en du ar it sp. Consequences on Chemotherapy Efficiency and Safety. HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy.
Risk factors of chronic kidney disease in HIV-infected patients.
Hepatitis E virus infection in patients infected with the human immunodeficiency virus. Relapse of hepatitis C virus after 14 months of sustained virological response following pegylated-interferon alpha plus ribavirin therapy in a human immunodeficiency virus type 1 infected patient.
Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: Antiretroviral therapy as a risk factor for chronic kidney disease: Infection par le VIH et parcours de soin: Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy.
C Med Mal Infect. J Med Virol Clin J Am Soc Nephrol. The challenge of geriatric patients. Results from a French prospective cohort.
A Cross- Sectional Analysis.
Discussion:Hépatite virale — Wikipédia
Tipranavir in highly antiretroviral treatment-experienced patients: Formulaire de recherche Recherche. HIV is associated with airway obstruction: Efficacy and tolerability of Etravirine in HIV-1 adult patients: Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIV.
Clin Res Hepatol Gastroenterol. Jepatites exposure and comorbidities in an aging HIV-infected population: Frailty in HIV infected people: Risk factors associated with overweight and obesity in HIV-infected people: Results from traditional regression modeling and causal approach in a large observational study. Eur J Clin Pharmacol.
viralles The spectrum of malignancies in HIV-infected patients in in France: Mandibular osteonecrosis and dental exfoliation after trigeminal zoster in an HIV-infected patient. Linked in Viadeo Youtube Email.
No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France. Acute and chronic hepatitis E in patients infected with human immunodeficiency virus. Changes over the past 10 years in France.
Aging, behavioral factors but not cART in a cross-sectional study. Impact on Tenofovir Ctrough but not on Renal Safety? Efficacy and safety of dolutegravir and rilpivirine dual therapy as 1 a simplification.
Cancer risk in HIV-infected patients: Mandibular osteonecrosis and dental exfoliation after trigeminal zoster in an HIV-infected patient: Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIVinfected patients.
Impact on tenofovir trough concentrations and renal safety. Mean cost of a first combination antiretroviral therapy in HIV-infected patients in France, and determinants of expensive drugs prescription.
What’s new in ? J Acquir Immune Defic Syndr. Human immunodeficiency virus infection and non-small cell hepatifes cancer: Impact of tenofovir trough concentration. Br J Clin Pharmacol. Renal impairment in patients receiving a tenofovir-cART regimen: